Company intelligence / Profile preview

Optimal Industrial Automation

Yate (Bristol), England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Optimal Industrial Automation provides automation and PAT solutions for pharma and biopharma manufacturing, including integration of real-time analytics and quality assurance. Their synTQ platform is widely adopted across the industry, supporting increased productivity, regulatory compliance, and deployment for both small molecule and biologics production. There are no proprietary therapeutics or clinical trials, as the company does not develop drugs but provides enabling technology used in commercial-scale manufacturing.[1][4][5][8]

Modalities: Small moleculeBiologicmRNA-based drugsMonoclonal antibody
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

BrukerVarious global pharmaceutical and biotechnology manufacturers (not specified individually)

Beyond the preview

Go deeper on Optimal Industrial Automation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optimal Industrial Automation.

Explore the full profile